Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
918 trades
$10.3T in total
Open-market sales
1,145 trades
$2B in total
Insiders filing
485 insiders
Last 7 days
Amylyx PharmaceuticalsAMLX
10,028 sh$324,86809/10Filed 09/11
Amylyx PharmaceuticalsAMLX
10,810 sh$349,82109/10Filed 09/11
Justin B. KleeOfficer, Director
Amylyx PharmaceuticalsAMLX
30,464 sh$980,26409/10Filed 09/11
Joshua B. CohenOfficer, Director
Amylyx PharmaceuticalsAMLX
30,464 sh$980,50409/10Filed 09/11
Amylyx PharmaceuticalsAMLX
9,536 sh$309,50609/10Filed 09/11
Amylyx PharmaceuticalsAMLX10b5-1 plan
30,000 sh$536,40007/09Filed 07/09
Amylyx PharmaceuticalsAMLX
7,909 sh$114,85203/02Filed 03/02
Amylyx PharmaceuticalsAMLX
6,461 sh$94,20503/02Filed 03/02
Justin B. KleeOfficer, Director
Amylyx PharmaceuticalsAMLX
29,282 sh$423,76003/02Filed 03/02
Joshua B. CohenOfficer, Director
Amylyx PharmaceuticalsAMLX
29,282 sh$424,12003/02Filed 03/02
Amylyx PharmaceuticalsAMLX
6,844 sh$99,37903/02Filed 03/02
Amylyx PharmaceuticalsAMLX
3,419 sh$48,35202/23Filed 02/23
Amylyx PharmaceuticalsAMLX
3,448 sh$50,51502/02Filed 02/02
Justin B. KleeOfficer, Director
Amylyx PharmaceuticalsAMLX
15,500 sh$227,61702/02Filed 02/02
Joshua B. CohenOfficer, Director
Amylyx PharmaceuticalsAMLX
15,500 sh$227,59302/02Filed 02/02
Amylyx PharmaceuticalsAMLX
3,557 sh$52,09702/02Filed 02/02
Justin B. KleeDirector, Officer
Amylyx PharmaceuticalsAMLX
1,995 sh$26,972.401/16Filed 01/16
Joshua B. CohenDirector, Officer
Amylyx PharmaceuticalsAMLX
1,974 sh$26,688.4801/16Filed 01/16
Joshua B. CohenDirector, Officer
Amylyx PharmaceuticalsAMLX
136,193 sh$1,916,235.5101/15Filed 01/15
Justin B. KleeDirector, Officer
Amylyx PharmaceuticalsAMLX
136,193 sh$1,916,235.5101/15Filed 01/15